The Acrylic Fibres Market size is poised to cross a valuation of US$ 5,470.6 million in 2023 and is predicted to hit a valuation of US$ 8,006.7 million by 2033. The acrylic fibre market share is estimated to expand at a CAGR of 4.2% from 2023 to 2033. Due to its characteristics, such as softness, …
Monthly Archives: August 2023
Textile Chemicals Market in Asia to Surge with 6% CAGR, Projected to Reach US$ 24,600 Million by 2033
As per the recent Asia Textile Chemicals Market analysis report released by FMI, following a growth of 7.4% during the period covering 2017 to 2022, the present valuation of the overall market has reached nearly US$ 14,200 Million in 2023. The Asia textile chemicals market is expected to develop at a rate of 6% from 2023 …
Necrobiosis Lipoidica Diabeticorum Market on the Rise | A Comprehensive Analysis of the Global Landscape and Forecasts
The global Necrobiosis Lipoidica Diabeticorum (NLD) Market Size is expected to garner a value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by registering a CAGR of 6% in the forecast period 2023-2033. The market for Necrobiosis Lipoidica Diabeticorum (NLD) registered a CAGR of 4% …
Rising Demand for Anti-Inflammatory Medications Drives Spine Pain Market Growth
According to Future Market Insights’ recent report, the Spine Pain Market forecast to register a CAGR of 5% from 2023 to 2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications’ minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as nonsteroidal …
Continue reading “Rising Demand for Anti-Inflammatory Medications Drives Spine Pain Market Growth”
Hyperphosphatemia Market Forecast | Growing Demand amid Increasing Chronic Renal Illnesses
According to Future Market Insights, the Hyperphosphatemia Market Sales would expand rapidly between 2023 and 2033. Worldwide sales of Hyperphosphatemia drugs are estimated to reach almost US$ 20.24 billion by 2033, with the market expected to grow at the same rate. Various calcium-based phosphorus binders are used as calcium supplements nowadays and can replace aluminum-based …
Innovative Biologic Medicines | Understanding PCSK9 Inhibitors and Their Impact on LDL Cholesterol
A recently published study by FMI expects the Global PCSK9 Inhibitors Market Demand to augment at a 15.8% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 Inhibitors …
Future Outlook | The Promising Frontier of Oncolytic Virus Cancer Therapy
According to a recent study published by Future Market Insights, the Market for Oncolytic Virus Cancer Therapy forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise awareness …
Continue reading “Future Outlook | The Promising Frontier of Oncolytic Virus Cancer Therapy”
Fucosidosis Therapeutics Landscape | Market Projections and Treatment Breakthroughs
The Global Fucosidosis Therapeutics Market Size is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Fucosidosis Therapeutics market grew at a 4% CAGR between 2018 and 2022. Fucosidosis is a rare lysosomal …
Donohue Syndrome Treatment Market on the Rise | A 4% CAGR Forecast from 2023 to 2033
According to a recent FMI analysis, the global Donohue Syndrome Treatment Market Demand is expected to grow at a 4% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 25 billion by the end of the assessment period. Donohue syndrome, also known as leprechaunism, is an extremely rare and severe …
Harnessing Research | Promising Outlook for Dystrophic Epidermolysis Bullosa Treatment Market
According to Future Market Insights, the global Dystrophic Epidermolysis Bullosa Management Market will increase at a compound annual growth rate (CAGR) of 5.7% between 2023 and 2033, reaching US$ 787.8 million by 2033. With increased research to cure this illness, the global market for dystrophic epidermolysis bullosa treatment is predicted to grow significantly throughout the …